Roxatidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171955This classification denotes an anti-ulcer agent and histamine h2 antagonist with the molecular formula C17H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IV9VHT3YUM, chemically known as acetamide, 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)- but generally known as roxatidine, which bears US NIH Compound Identifier 91276. European Medicines Agency schedules Roxatidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10396MIG. World Health Organization schedules roxatidine in its Anatomical Therapeutic Chemical (ATC) Classification. ROXATIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roxatidine under HS 29333999 and SITC 51574. As of Q4 2014, ROXATIDINE remains the US FDA Preferred Term for this commodity. SMILES: O(C1CC(CN2CCCCC2)CCC1)CCCNC(=O)CO.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.